Skip to search formSkip to main contentSkip to account menu

Oncovin-Etoposide-Prednisone-Adriamycin Regimen (OEPA Regimen)

Known as: GPOH-HD 95 Regimen, OEPA Regimen, OEPA 
A regimen consisting of vincristine, etoposide, prednisone and doxorubicin for the treatment of male patients with childhood Hodgkin's lymphoma.
National Institutes of Health

Related topics

Related topics

5 relations
DoxorubicinEtoposidePrednisoneVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Optimal Placement of Virtual Machines for Supporting Multiple Applications in Mobile Edge Networks
Although mobile edge computing (MEC), as an extension of the cloud computing paradigm to edge networks, overcomes some obstacles… 
Review
2016
Review
2016
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma
Purpose The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin… 
2015
2015
Growth, Challenges, and Solutions over 25 Years of Mectizan and the Impact on Onchocerciasis Control
The Mectizan Donation Program (MDP) was established in 1987 to oversee Merck’s donation of Mectizan (ivermectin, MSD) for the… 
Highly Cited
2014
Highly Cited
2014
qPET – a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma
BackgroundInterim FDG-PET is used for treatment tailoring in lymphoma. Deauville response criteria consist of five ordinal… 
Highly Cited
2013
Highly Cited
2013
Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?
PurposeWith the recent introduction of PET/MRI, we investigated whether diffusion-weighted imaging (DWI) can complement PET for… 
2011
2011
Assessing the Performance of Evapotranspiration Covers for Municipal Solid Waste Landfills in Northwestern Ohio
Evapotranspiration (ET) covers have gained considerable interest as an alternative to conventional covers for the final closure… 
Review
2003
Review
2003
Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.
BACKGROUND In 5 consecutive pediatric and adolescent Hodgkin's disease trials DAL-HD since 1978 the invasive diagnostic… 
Highly Cited
1998
Highly Cited
1998
The Onchocerciasis Elimination Program for the Americas: a history of partnership.
The decision in 1987 by the pharmaceutical firm Merck & Co. to provide Mectizan (ivermectin) free of charge to river blindness… 
Highly Cited
1992
Highly Cited
1992
Day Versus Night Electrofishing Catches from Near-Shore Waters of the Ohio and Muskingum Rivers
Author Institution: Division of Water Quality Planning and Assessment, State of Ohio Environmental Protection Agency 
Highly Cited
1979
Highly Cited
1979
International agency for the prevention of blindness.
Acknowledgements IAPB is a collaborative organisation, and this document was made possible by many expert contributors from… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)